US Global Investors Inc
Change company Symbol lookup
Select an option...
GROW US Global Investors Inc
MP Mp Materials Corp
WFG West Fraser Timber Co Ltd
MDT Medtronic PLC
ATMR^ Altimar Acquisition Corp II
AEG Aegon NV
MGP MGM Growth Properties LLC
WRB W R Berkley Corp
ABBV Abbvie Inc
SUIC Sino United Worldwide Consolidated Ltd
Go

Financials : Capital Markets | Small Cap Growth
Company profile

U.S. Global Investors, Inc. is an investment advisor. The Company operates through two business segments: providing investment management services to the United States Global Investors Funds (USGIF) and an exchange traded fund (ETF) clients, and investing for its own account. It operates in San Antonio, Texas. The Company furnishes an investment program for each of the clients it manages and determines, subject to overall supervision by the applicable board of trustees of the clients, the clients' investments pursuant to an advisory agreement. Consistent with the investment restrictions, objectives and policies of the particular client, the portfolio team for each client determines what investments should be purchased, sold and held, and makes changes in the portfolio deemed. The Company also manages, supervises and conducts certain other affairs of USGIF. In addition to providing management and advisory services, the Company is engaged in trading for its own account.

Closing Price
$6.22
Day's Change
0.125 (2.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.28
Day's Low
6.06
Volume
(Above Average)
Volume:
187,538

10-day average volume:
161,653
187,538

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CYDY, NEPT and ACAD

12:30 pm ET May 6, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

CytoDyn Inc. (OTCQB:CYDY)

Investors Affected : March 27, 2020 - March 9, 2021

A class action has commenced on behalf of certain shareholders in CytoDyn Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.

Shareholders may find more information at https://securitiesclasslaw.com/securities/cytodyn-inc-loss-submission-form/?id=15563&from=1

Neptune Wellness Solutions Inc. (NASDAQ:NEPT)

Investors Affected : July 24, 2019 - February 16, 2021

A class action has commenced on behalf of certain shareholders in Neptune Wellness Solutions Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/neptune-wellness-solutions-inc-loss-submission-form/?id=15563&from=1

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

Investors Affected : June 15, 2020 - April 4, 2021

A class action has commenced on behalf of certain shareholders in Acadia Pharmaceuticals Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/acadia-pharmaceuticals-inc-loss-submission-form/?id=15563&from=1

Image: https://www.accesswire.com/users/newswire/images/645377/grosslawlogo.jpg

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm

15 West 38th Street, 12th floor

New York, NY, 10018

Email: dg@securitiesclasslaw.com

Phone: (212) 537-9430

Fax: (833) 862-7770

SOURCE: The Gross Law Firm

View source version on accesswire.com:

https://www.accesswire.com/645377/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-CYDY-NEPT-and-ACAD

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.